230 related articles for article (PubMed ID: 31968702)
41. Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus.
Lan J; Deng Y; Song J; Huang B; Wang W; Tan W
Virol Sin; 2018 Oct; 33(5):453-455. PubMed ID: 30374826
[No Abstract] [Full Text] [Related]
42. Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies.
Song F; Fux R; Provacia LB; Volz A; Eickmann M; Becker S; Osterhaus AD; Haagmans BL; Sutter G
J Virol; 2013 Nov; 87(21):11950-4. PubMed ID: 23986586
[TBL] [Abstract][Full Text] [Related]
43. Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus.
Deng Y; Lan J; Bao L; Huang B; Ye F; Chen Y; Yao Y; Wang W; Qin C; Tan W
Emerg Microbes Infect; 2018 Apr; 7(1):60. PubMed ID: 29618723
[TBL] [Abstract][Full Text] [Related]
44. [Novel Research Progress of the Recombinant Vaccine for MERS-CoV].
Hu H; Shen Y
Bing Du Xue Bao; 2016 Jul; 32(4):495-500. PubMed ID: 29995374
[TBL] [Abstract][Full Text] [Related]
45. Prospects for a MERS-CoV spike vaccine.
Zhou Y; Jiang S; Du L
Expert Rev Vaccines; 2018 Aug; 17(8):677-686. PubMed ID: 30058403
[TBL] [Abstract][Full Text] [Related]
46. Antibodies and vaccines against Middle East respiratory syndrome coronavirus.
Xu J; Jia W; Wang P; Zhang S; Shi X; Wang X; Zhang L
Emerg Microbes Infect; 2019; 8(1):841-856. PubMed ID: 31169078
[TBL] [Abstract][Full Text] [Related]
47. Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen.
Lan J; Deng Y; Chen H; Lu G; Wang W; Guo X; Lu Z; Gao GF; Tan W
PLoS One; 2014; 9(11):e112602. PubMed ID: 25405618
[TBL] [Abstract][Full Text] [Related]
48. [Bioinformatics-based Design of Peptide Vaccine Candidates Targeting Spike Protein of MERS-CoV and Immunity analysis in Mice].
Lan J; Lu S; Deng Y; Wen B; Chen H; Wang W; Tan W
Bing Du Xue Bao; 2016 Jan; 32(1):77-81. PubMed ID: 27295887
[TBL] [Abstract][Full Text] [Related]
49. CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice.
Veit S; Jany S; Fux R; Sutter G; Volz A
Viruses; 2018 Dec; 10(12):. PubMed ID: 30558354
[TBL] [Abstract][Full Text] [Related]
50. MERS-CoV spike protein: Targets for vaccines and therapeutics.
Wang Q; Wong G; Lu G; Yan J; Gao GF
Antiviral Res; 2016 Sep; 133():165-77. PubMed ID: 27468951
[TBL] [Abstract][Full Text] [Related]
51. Stabilized coronavirus spike stem elicits a broadly protective antibody.
Hsieh CL; Werner AP; Leist SR; Stevens LJ; Falconer E; Goldsmith JA; Chou CW; Abiona OM; West A; Westendorf K; Muthuraman K; Fritch EJ; Dinnon KH; Schäfer A; Denison MR; Chappell JD; Baric RS; Graham BS; Corbett KS; McLellan JS
Cell Rep; 2021 Nov; 37(5):109929. PubMed ID: 34710354
[TBL] [Abstract][Full Text] [Related]
52. Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein.
Volz A; Kupke A; Song F; Jany S; Fux R; Shams-Eldin H; Schmidt J; Becker C; Eickmann M; Becker S; Sutter G
J Virol; 2015 Aug; 89(16):8651-6. PubMed ID: 26018172
[TBL] [Abstract][Full Text] [Related]
53. Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein.
Rodon J; Okba NMA; Te N; van Dieren B; Bosch BJ; Bensaid A; Segalés J; Haagmans BL; Vergara-Alert J
Emerg Microbes Infect; 2019; 8(1):1593-1603. PubMed ID: 31711379
[TBL] [Abstract][Full Text] [Related]
54. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein.
Widjaja I; Wang C; van Haperen R; Gutiérrez-Álvarez J; van Dieren B; Okba NMA; Raj VS; Li W; Fernandez-Delgado R; Grosveld F; van Kuppeveld FJM; Haagmans BL; Enjuanes L; Drabek D; Bosch BJ
Emerg Microbes Infect; 2019; 8(1):516-530. PubMed ID: 30938227
[TBL] [Abstract][Full Text] [Related]
55. Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice.
Gutiérrez-Álvarez J; Honrubia JM; Sanz-Bravo A; González-Miranda E; Fernández-Delgado R; Rejas MT; Zúñiga S; Sola I; Enjuanes L
Proc Natl Acad Sci U S A; 2021 Oct; 118(43):. PubMed ID: 34686605
[TBL] [Abstract][Full Text] [Related]
56. Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.
Tang XC; Agnihothram SS; Jiao Y; Stanhope J; Graham RL; Peterson EC; Avnir Y; Tallarico AS; Sheehan J; Zhu Q; Baric RS; Marasco WA
Proc Natl Acad Sci U S A; 2014 May; 111(19):E2018-26. PubMed ID: 24778221
[TBL] [Abstract][Full Text] [Related]
57. Rhabdovirus-based vaccine platforms against henipaviruses.
Kurup D; Wirblich C; Feldmann H; Marzi A; Schnell MJ
J Virol; 2015 Jan; 89(1):144-54. PubMed ID: 25320306
[TBL] [Abstract][Full Text] [Related]
58. Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.
Shi J; Zhang J; Li S; Sun J; Teng Y; Wu M; Li J; Li Y; Hu N; Wang H; Hu Y
PLoS One; 2015; 10(12):e0144475. PubMed ID: 26641892
[TBL] [Abstract][Full Text] [Related]
59. MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques.
Wang C; Zheng X; Gai W; Zhao Y; Wang H; Wang H; Feng N; Chi H; Qiu B; Li N; Wang T; Gao Y; Yang S; Xia X
Oncotarget; 2017 Feb; 8(8):12686-12694. PubMed ID: 27050368
[TBL] [Abstract][Full Text] [Related]
60. A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies.
Faber M; Lamirande EW; Roberts A; Rice AB; Koprowski H; Dietzschold B; Schnell MJ
J Gen Virol; 2005 May; 86(Pt 5):1435-1440. PubMed ID: 15831955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
